---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-000383"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2022-01-05T23:59:59+00:00"
generated_at: "2026-06-27T20:35:16.452696+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed agrees to acquire Kind Therapeutics USA for $20M; buys minority interests for $2M

## Summary
- Acquires 100% of Kind Therapeutics for $20M: $13.5M cash, $6.5M in 4-year 6% promissory notes.
- Also buys minority interests in two subsidiaries for $2M, gaining ~99.7% of Mari-MD and ~94.3% of Mia.
- Kind holds Maryland medical cannabis licenses for cultivation, production, and provisional dispensary.
- Closing subject to Maryland Medical Cannabis Commission approval; related litigation dismissed with prejudice.
- CEO Bob Fireman expects another transformational year; MariMed already manages Kind's operations.

## SEC filing metadata
- accession: 0001493152-22-000383
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2022-01-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/0001493152-22-000383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-000383
- JSON: https://secwatch.observer/filing/0001493152-22-000383.json
- Plain text: https://secwatch.observer/filing/0001493152-22-000383.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.